Do you want to live long and be healthy? Refer to Shivom

Thanks to genetics in 1953, mankind learned that all information about a living organism is contained in the DNA molecule code.

In 2003, a group of scientists led by American geneticists were able to decipher the human genome. Researchers have managed to establish what kind of variations each human gene has - and this can help in understanding which genetic disease it responds to. Scientists have already managed to understand which genetic variations are responsible for the onset of heart muscle (myocardium) disease, chronic inflammation of the gastrointestinal tract, sickle cell anemia (hemoglobin disorders) or Gaucher disease, a hereditary disease that leads to the accumulation of complex fats in many tissues, including the spleen, liver, kidneys, lungs, brain and bone marrow.

The analysis of the genome is called sequencing - the determination of the primary sequence of nucleotides in the composition of macromolecules carrying hereditary information. The cost of sequencing is quite high - about several thousand dollars. Sequencing is done in two stages: first the gene is analyzed, then its decoding takes place. After that, the data is written to the hard disk and handed to the client.

However, at this stage, there are problems: what the client does next with the information received, who he can carry it to, who will be able to read it, who will be able to see it at all.

Asked the same questions, the company Shivom has developed the largest densentralized genomic data center Shivom.

Thanks to Shivom technology, everyone can get their genome, store it in a blockchain and, if necessary, give access to it to medical and pharmacological companies, individuals.

The Shivom ecosystem will offer an open web market for other providers to add their applications and services, along with analytics of genomic data and personalization of medicines.

Thanks to Shivom, the cost of DNA sequencing has dropped dramatically. It is expected that by 2020 it will be less than $ 500.

Sequencing the genome has many advantages:

• diagnosis of genetic diseases;
• the best course of treatment is determined, including selection of the most effective drug and dosage;
• it is possible to conduct correct prophylaxis of genetic diseases;
• indicates the level of risk of the disease;
• prognosis of the course of the disease.

Selling tokens

For the development of the Shivom project, the team conducts the initial offering of internal OmiX tokens. The preliminary sale of the tokens started on April 16 and will last until April 27, 2018. The bonus is 3%.

The main sale of tokens will take place from 3 to 9 May 2018.
Total issued 3 million 000 OmiX tokens.
Of these, 990,000,000 OmiX tokens are offered for sale.

Price 1 OmiX = 0.0775 USD
Purpose of charges: 35 million US dollars.
Accepted for payment: ETH, BTC, USD.

The Shivom project is a revolutionary breakthrough in the world of medicine, diagnostics on the basis of the blockchain. We have a real opportunity to get answers to many questions regarding our health and longevity. And the OmiX token will be an excellent source of profitability for your crypto portfolios, dear crypto investors!

Also, please pay attention to the list of respected partners of Shivom. These are well-known and successful companies.

More information about the benefits of the Shivom project, the development team, the terms of purchase of the tokens you can find on the official sites of the project:

Website
Ann Thread
Whitepaper
Facebook
Twitter
Telegram
Reddit
Medium
YouTube

Author: happy weblancer